{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:00Z","timestamp":1792601460457,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T00:00:00Z","timestamp":1335312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00296-012-2375-7","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T22:03:37Z","timestamp":1335305017000},"page":"697-703","source":"Crossref","is-referenced-by-count":73,"title":["Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage"],"prefix":"10.1007","volume":"33","author":[{"given":"Mona Helmy","family":"Abdel Meguid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousry Hasan","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania Shafek","family":"Swilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Samy","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,25]]},"reference":[{"key":"2375_CR1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.0105-2896.2005.00338.x","volume":"208","author":"NC Walsh","year":"2005","unstructured":"Walsh NC, Crotti TN, Coldring SR, Gravallese EM (2005) Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 208:228\u2013251","journal-title":"Immunol Rev"},{"key":"2375_CR2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestern","year":"2003","unstructured":"Firestern GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356\u2013361","journal-title":"Nature"},{"key":"2375_CR3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1521-6942(03)00041-X","volume":"17","author":"TR Mikuls","year":"2003","unstructured":"Mikuls TR (2003) Co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 17:729\u2013752","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2375_CR4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.berh.2007.05.007","volume":"21","author":"A Young","year":"2007","unstructured":"Young A, Koduri G (2007) Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol 21:907\u2013927","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2375_CR5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.62.7.617","volume":"62","author":"DH Forsblad","year":"2003","unstructured":"Forsblad DH, Larsen A, Waltbrand E, Kvist G, Mellstrom D, Saxne T, Ohlsson C, Nordborg E, Carlsten H (2003) Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalized osteoporosis. Ann Rheum Dis 62:617\u2013623","journal-title":"Ann Rheum Dis"},{"key":"2375_CR6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.rdc.2006.07.002","volume":"32","author":"L Sinigaglia","year":"2006","unstructured":"Sinigaglia L, Varenna M, Girasole G, Bianchi G (2006) Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin N Am 32:631\u2013658","journal-title":"Rheum Dis Clin N Am"},{"key":"2375_CR7","first-page":"257","volume":"10","author":"H Kroger","year":"1994","unstructured":"Kroger H, Honkanen R, Saarikoski S, Alhava E (1994) Decreased axial bone mineral density in elderly women. The study of Osteoporotic Fractures Research Group. J Bone Miner Res 10:257\u2013263","journal-title":"J Bone Miner Res"},{"key":"2375_CR8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jbmr.5650100212","volume":"10","author":"NE Lane","year":"1995","unstructured":"Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC (1995) Rheumatoid arthritis and bone mineral density in elderly women. The study of Osteoporotic Fractures Research Group. J Bone Miner Res 10:257\u2013263","journal-title":"J Bone Miner Res"},{"key":"2375_CR9","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"TP Staa Van","year":"2006","unstructured":"Van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthr Rheum 54:3104\u20133112","journal-title":"Arthr Rheum"},{"key":"2375_CR10","first-page":"164","volume":"45","author":"P Emery","year":"1991","unstructured":"Emery P, Salmon M (1991) The immune response. 2, Systemic mediators of inflammation. Br J Hosp Med 45:164\u2013168","journal-title":"Br J Hosp Med"},{"key":"2375_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"TS Kwan","year":"2004","unstructured":"Kwan TS, Padrines M, Theoleyre S, Heymann D, Fortun Y (2004) IL-6, RANKL, TNF-alpha\/IL-l: inter relations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15:49\u201360","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Suppl 3","key":"2375_CR12","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1186\/ar565","volume":"4","author":"T Naka","year":"2002","unstructured":"Naka T, Nishimoto N, Kishimoto T (2002) The paradigm of IL-6: from basic science to medicine. Arthr Res 4(Suppl 3):S233\u2013S242","journal-title":"Arthr Res"},{"key":"2375_CR13","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/art.22175","volume":"54","author":"F Benedetn De","year":"2006","unstructured":"De Benedetn F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, Vivarelli M, Muratori F, Berni S, Ballanti P, Ferrari S, Teti A (2006) Impaired skeletal development in interleukin-6-transgenic mice, a model for the impact of chronic inflammation on the growing skeletal system. Arthr Rheum 54:3551\u20133563","journal-title":"Arthr Rheum"},{"key":"2375_CR14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0145-305X(97)00029-3","volume":"21","author":"WB Ershler","year":"1997","unstructured":"Ershler WB, Harman SM, Keller ET (1997) Immunologic aspects of osteoporosis. Dev Comp Immunol 21:487\u2013499","journal-title":"Dev Comp Immunol"},{"key":"2375_CR15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1359\/jbmr.1998.13.3.393","volume":"13","author":"RD Devlin","year":"1998","unstructured":"Devlin RD, Reddy SV, Savino R, Ciliberto G, Roodman GD (1998) IL-6 mediates the effects of IL-l or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures. J Bone Miner Res 13:393\u2013399","journal-title":"J Bone Miner Res"},{"key":"2375_CR16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","volume":"275","author":"T Nakashima","year":"2000","unstructured":"Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H (2000) Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biophys Res Commun 275:768\u2013775","journal-title":"Biophys Res Commun"},{"issue":"3","key":"2375_CR17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jbspin.2010.03.002","volume":"77","author":"B Goff Le","year":"2010","unstructured":"Le Goff B, Blanchard F, Berthelot JM, Heymann D, Maugars Y (2010) Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Jt Bone Spine 77(3):201\u2013205","journal-title":"Jt Bone Spine"},{"key":"2375_CR18","first-page":"2382","volume":"34","author":"F Burkhaer","year":"2007","unstructured":"Burkhaer F, Haindl P, Maktari A, Nothngal T et al (2007) Diseases activity score-28 values differ considerably depending on patient\u2019s pain perception and sex. J Rheumatol 34:2382\u20132387","journal-title":"J Rheumatol"},{"key":"2375_CR19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/ar1220","volume":"6","author":"E Krishman","year":"2004","unstructured":"Krishman E, Tugwell F, Fries JF (2004) Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as quality indicator (QI). Arthr Res Ther 6:505\u2013513","journal-title":"Arthr Res Ther"},{"key":"2375_CR20","unstructured":"Dacie JV, Lewis SM (1994) Basic haematologic techniques. In: Practical haematology, 7th edn. Churchill Livingstone, Edinburg, pp 37\u201366"},{"issue":"4","key":"2375_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-104-4-515","volume":"104","author":"HC Sox","year":"1986","unstructured":"Sox HC, Liang MH (1986) The erythrocyte sedimentation rate. Guidelines for rational use. Ann Int Med 104(4):515\u2013523","journal-title":"Ann Int Med"},{"key":"2375_CR22","first-page":"393","volume":"37","author":"D Ritche","year":"1988","unstructured":"Ritche D, Boyle JA, Innes JM (1988) Clinical studies with an articular index for assessment of joint tenderness in patient with rheumatoid arthritis. Q J Med 37:393\u2013406","journal-title":"Q J Med"},{"key":"2375_CR23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/ard.49.10.757","volume":"49","author":"MG Jones","year":"1990","unstructured":"Jones MG et al (1990) Specificity of rheumatoid factor in relation to the disease state in rheumatoid arthritis. Ann Rheum Dis 49:757\u2013762","journal-title":"Ann Rheum Dis"},{"key":"2375_CR24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","volume":"47","author":"N Bizzaro","year":"2001","unstructured":"Bizzaro N et al (2001) Diagnostic accuracy of anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47:1089\u20131093","journal-title":"Clin Chem"},{"key":"2375_CR25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","volume":"93","author":"C Ding","year":"2008","unstructured":"Ding C, Parameswaran V, Udayan R, Burgess J, Jones G (2008) Circulating levels of inflammatory markers predict change in bone mineral and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 93:1952\u20131958","journal-title":"J Clin Endocrinol Metab"},{"key":"2375_CR26","doi-asserted-by":"crossref","unstructured":"Kennedy AC, Smith DA, Buchanan WW, Anderson JB, Jasani MK (1937) Bone loss in patients with rheumatoid arthritis 4:73\u201379","DOI":"10.3109\/03009747509095618"},{"key":"2375_CR27","first-page":"833","volume-title":"Textbook of rheumatology","author":"ED Harris Jr","year":"1993","unstructured":"Harris ED Jr (1993) Etiology, pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (eds) Textbook of rheumatology, vol 1, 4th edn. WB Saunders, Philadelphia, pp 833\u2013873","edition":"4"},{"key":"2375_CR28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780300701","volume":"30","author":"PN Sambrook","year":"1987","unstructured":"Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S (1987) Determinants of axial bone loss in rheumatoid arthritis. Arthr Rheum 30:721\u2013728","journal-title":"Arthr Rheum"},{"issue":"Suppl 3","key":"2375_CR29","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1007\/BF03194376","volume":"7","author":"Y Suzki","year":"1997","unstructured":"Suzki Y, Mizushima Y (1997) Osteoporosis in rheumatoid arthritis. Osteoporos Int 7(Suppl 3):S217\u2013S222","journal-title":"Osteoporos Int"},{"issue":"3","key":"2375_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jbspin.2010.03.002","volume":"77","author":"B Goff Le","year":"2010","unstructured":"Le Goff B, Blanchard F, Berthelot JM, Heymann D, Maugars Y (2010) Role of interleukin-6 in structural and systemic bone loss in rheumatoid arthritis. Jt Bone Spine 77(3):201\u2013205","journal-title":"Jt Bone Spine"},{"issue":"10","key":"2375_CR31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/ard.45.10.852","volume":"45","author":"A Verstraeten","year":"1986","unstructured":"Verstraeten A, Dequeker J (1986) Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 45(10):852\u2013857","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2375_CR32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.48.7.535","volume":"48","author":"PN Sambrook","year":"1989","unstructured":"Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48(7):535\u2013538","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2375_CR33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2362.1992.tb01490.x","volume":"22","author":"H Kr\u00f6ger","year":"1992","unstructured":"Kr\u00f6ger H, Laitinen K (1992) Bone mineral density measured by dual-energy X-ray absorptiometry in normal men. Eur J Clin Invest 22(7):454\u2013460","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2375_CR34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1148\/radiology.170.2.2911675","volume":"170","author":"M O\u2019Malley","year":"1989","unstructured":"O\u2019Malley M, Kenrick AJ, Sartoris DJ, Hochberg AM, Weisman MH, Ramos E, Zvaifler N, Resnick D (1989) Axial bone density in rheumatoid arthritis: comparison of dual-energy projection radiography and dual-photon absorptiometry. Radiology 170(2):501\u2013505","journal-title":"Radiology"},{"issue":"6","key":"2375_CR35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/ard.44.6.406","volume":"44","author":"OS Als","year":"1985","unstructured":"Als OS, Gotfredsen A, Riis BJ, Christiansen C (1985) Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis? Ann Rheum Dis 44(6):406\u2013411","journal-title":"Ann Rheum Dis"},{"key":"2375_CR36","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00198-010-1192-7","volume":"21","author":"CJ Edwards","year":"2010","unstructured":"Edwards CJ, Williams E (2010) The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis. Osteoporos Int 21:1287\u20131293","journal-title":"Osteoporos Int"},{"key":"2375_CR37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0531-5565(00)00220-5","volume":"36","author":"N Giuliani","year":"2010","unstructured":"Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, Padrazzoni M (2010) Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age and menopause-related changes. Exp Gerontol 36:547\u2013557","journal-title":"Exp Gerontol"},{"key":"2375_CR38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/jc.2002-020092","volume":"88","author":"SL Ferrari","year":"2003","unstructured":"Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL (2003) Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of c-reactive protein and markers of bone resorption in postmenopausal women. J Endocrinol Metab 88:225\u2013229","journal-title":"J Endocrinol Metab"},{"issue":"11","key":"2375_CR39","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/ard.45.11.950","volume":"45","author":"PN Sambrook","year":"1986","unstructured":"Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD (1986) Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis 45(11):950\u2013953","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2375_CR40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.1780271205","volume":"27","author":"JR Hooyman","year":"1984","unstructured":"Hooyman JR, Melton LJ III, Nelson AM, O\u2019Fallon WM, Riggs BL (1984) Fractures after rheumatoid arthritis. A population-based study. Arthr Rheum 27(12):1353\u20131361","journal-title":"Arthr Rheum"},{"issue":"2","key":"2375_CR41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00291149","volume":"11","author":"M Magaro","year":"1991","unstructured":"Magaro M, Tricerri A, Piane D, Zoli A, Serra F, Altomonte L, Mirone L (1991) Generalized osteoporosis in non-steroid treated rheumatoid arthritis. Rheumatol Int 11(2):73\u201376","journal-title":"Rheumatol Int"},{"issue":"7","key":"2375_CR42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780300701","volume":"30","author":"PN Sambrook","year":"1987","unstructured":"Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S (1987) Determinants of axial bone loss in rheumatoid arthritis. Arthr Rheum 30(7):721\u2013728","journal-title":"Arthr Rheum"},{"issue":"3","key":"2375_CR43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/rheumatology\/25.3.253","volume":"25","author":"DM Reid","year":"1986","unstructured":"Reid DM, Kennedy NS, Smith MA, Nicoll J, Brown N, Tothill P, Nuki G (1986) Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis: effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements. Br J Rheumatol 25(3):253\u2013259","journal-title":"Br J Rheumatol"},{"issue":"4","key":"2375_CR44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780280403","volume":"28","author":"OS Als","year":"1985","unstructured":"Als OS, Gotfredsen A, Christiansen C (1985) The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state. Arthr Rheum 28(4):369\u2013375","journal-title":"Arthr Rheum"},{"key":"2375_CR45","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"MR McClung","year":"2006","unstructured":"McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodsen GC, Moffett AH et al (2006) Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 354:821\u2013831","journal-title":"N Engl J Med"},{"key":"2375_CR46","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, and the Denosumab Rheumatoid Arthritis Study Group et al (2008) Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelvemonth, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthr Rheum 58:1299\u20131309","journal-title":"Arthr Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2375-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2375-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2375-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T14:41:51Z","timestamp":1594046511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2375-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,25]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2375-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,25]]}}}